
Michelle Dalton, ELS
Advertisement
Articles by Michelle Dalton, ELS








This year’s ASRS PAT survey show subtle regional differences

The ASRS Global Trends Survey finds differences in some treatment preferences


Group of researchers aim to validate both approaches in proof-of-concept study







Fifteen fellows, residents showed just why research in retina is on the cutting edge









Research finds limited publications and dearth of information about side effects

Findings from the PERMEATE study used novel diagnostics to quantify response to intravitreal injections


When used one week after injection, optical coherence tomography angiography can help clinicians determine how effective their treatment has been on neovascular membrane reperfusion.
Advertisement
Advertisement
Advertisement
Trending on Modern Retina
1
Eichenbaum Acorns: Collaborative retina care with Jeffry D. Gerson, OD, FAAO
2
NovaBridge, Visara report positive phase 2a results for dual VEGF-A/ANG-2 inhibitor VIS-101
3
FDA clears phase I/II trial of SVT-001 cell therapy for familial drusen–associated vision loss
4
Johnson & Johnson’s TECNIS PureSee EDOF IOL cleared for US market
5